APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE BY ACTIVATING THE NALP3 INFLAMMASOME VIA A NOVEL MOLECULAR PATHWAY

被引:0
|
作者
Zewinger, Stephen [2 ]
Jankowski, Vera [3 ]
Jennings, Richard [2 ]
Petrakis, Ioannis [2 ]
Maerz, Winfried [4 ]
Jankowski, Joachim [3 ]
Laufs, Ulrich [2 ]
Fliser, Danilo [2 ]
Speer, Thimoteus [1 ]
机构
[1] Saarland Univ Hosp, Dept Internal Med 4, Homburg, Germany
[2] Saarland Univ Hosp, Dept Internal Med 4, Homburg, Germany
[3] Univ Aachen, Inst Mol Cardiovasc Res, Aachen, Germany
[4] Heidelberg Univ, Nephrol, Med Fac Mannheim, Mannheim, Germany
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO031
引用
收藏
页码:56 / 57
页数:2
相关论文
共 17 条
  • [1] APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION AND ORGAN DAMAGE IN CKD BY ALTERNATIVE INFLAMMASOME ACTIVATION VIA A NOVEL PATHWAY
    Zewinger, Stephen
    Jochen, Reiser
    Jankowski, Vera
    Hahm, Eunsil
    Schunk, Stefan
    Schmit, David
    Maerz, Winfried
    Jankowski, Joachim
    Barbara, Niemeyer
    Laufs, Ulrich
    Fliser, Danilo
    Speer, Thimoteus
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [2] Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
    Stephen Zewinger
    Jochen Reiser
    Vera Jankowski
    Dalia Alansary
    Eunsil Hahm
    Sarah Triem
    Mira Klug
    Stefan J. Schunk
    David Schmit
    Rafael Kramann
    Christina Körbel
    Emmanuel Ampofo
    Matthias W. Laschke
    Simina-Ramona Selejan
    Anna Paschen
    Tobias Herter
    Susanne Schuster
    Günther Silbernagel
    Martina Sester
    Urban Sester
    Gunter Aßmann
    Robert Bals
    Gerhard Kostner
    Willi Jahnen-Dechent
    Michael D. Menger
    Lucia Rohrer
    Winfried März
    Michael Böhm
    Joachim Jankowski
    Manfred Kopf
    Eicke Latz
    Barbara A. Niemeyer
    Danilo Fliser
    Ulrich Laufs
    Thimoteus Speer
    Nature Immunology, 2020, 21 : 30 - 41
  • [3] Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
    Zewinger, Stephen
    Reiser, Jochen
    Jankowski, Vera
    Alansary, Dalia
    Hahm, Eunsil
    Triem, Sarah
    Klug, Mira
    Schunk, Stefan J.
    Schmit, David
    Kramann, Rafael
    Koerbel, Christina
    Ampofo, Emmanuel
    Laschke, Matthias W.
    Selejan, Simina-Ramona
    Paschen, Anna
    Herter, Tobias
    Schuster, Susanne
    Silbernagel, Guenther
    Sester, Martina
    Sester, Urban
    Assmann, Gunter
    Bals, Robert
    Kostner, Gerhard
    Jahnen-Dechent, Willi
    Menger, Michael D.
    Rohrer, Lucia
    Maerz, Winfried
    Boehm, Michael
    Jankowski, Joachim
    Kopf, Manfred
    Latz, Eicke
    Niemeyer, Barbara A.
    Fliser, Danilo
    Laufs, Ulrich
    Speer, Thimoteus
    NATURE IMMUNOLOGY, 2020, 21 (01) : 30 - +
  • [4] Involvement of NALP3 inflammasome and NFKAPPAB in the development of endothelial dysfunction in advanced chronic kidney disease: protective role of antioxidant molecules
    Caballo, C.
    Palomo, M.
    Cases, A.
    Molina, P.
    Vera, M.
    Bosch, X.
    Escolar, G.
    Diaz-Ricart, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 487 - 488
  • [5] Toll-like receptor 4 and the inflammasome NALP3 mediate the activation and damage of endothelial cells in advance chronic kidney disease: protective effect of defibrotide
    Martin, S.
    Caballo, C.
    Molina, P.
    Gutierrez, G.
    Vera, M.
    Cases, A.
    Escolar, G.
    Diaz-Ricart, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 652 - 652
  • [6] High molecular-weight dextran sulfate induces fragmentation of C3 without activating classical and alternative pathway
    Murakami, Y
    Kitano, E
    Iwata, H
    Kitamura, H
    Ikada, Y
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 382 - 382
  • [7] Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study
    Pan, Binbin
    Wan, Xin
    Ma, Mengqing
    Cao, Changchun
    KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (01): : 61 - 69
  • [8] Chlamydial plasmid-encoded protein pORF5 induces production of IL-1β and IL-18 via NALP3 inflammasome activation and p38 MAPK pathway
    Cao, Wenjuan
    Zou, Yan
    Su, Shengmei
    He, Zhansheng
    Liu, Yan
    Huang, Qiulin
    Li, Zhongyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 20368 - 20379
  • [9] Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1/IL-1R1/MyD88/NF-B pathway
    Song, Cheng
    He, Lujuan
    Zhang, Jin
    Ma, Hong
    Yuan, Xiangning
    Hu, Gaoyun
    Tao, Lijian
    Zhang, Jian
    Meng, Jie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (11) : 2064 - 2077
  • [10] A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway
    Dai, Lei
    Chen, Yu
    Wu, Jinhua
    He, Zhen
    Zhang, Yueqi
    Zhang, Wenjun
    Xie, Yang
    Zeng, Hesong
    Zhong, Xiaodan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)